Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

An Alabama Senate committee unanimously approved a bill Wednesday morning that would require health insurance companies to ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

A marathon runner has said a prostrate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has run 19 marathons since the age of 50, was diagnosed eight years ago after ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.